insights_auto
Why is EDIT up 3,97%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
2,62 $
arrow_upward
+3,97%(+0,100) 1D
2,60 $
arrow_downward
-0,76% (-0,020)bedtimeAfter hours
Closed: 2 հոկ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,57 $
High
2,63 $
Low
2,51 $
Mkt. cap
402,38 մլն
Avg. vol.
2,95 մլն
Volume
2,16 մլն
52-wk high
4,54 $
52-wk low
1,66 $
EPS
-0,74 $
Beta
2,00
Shares outstanding
153,58 մլն
No. of employees
87
Open
2,57 $
High
2,63 $
Low
2,51 $
Mkt. cap
402,38 մլն
Avg. vol.
2,95 մլն
Volume
2,16 մլն
52-wk high
4,54 $
52-wk low
1,66 $
EPS
-0,74 $
Beta
2,00
Shares outstanding
153,58 մլն
No. of employees
87
News stories
From web sources and news partners
Renaissance Capital
·
34 րոպե առաջ
GBC IPO News - Atlanta area bank Georgia Banking Company files for a direct listing on the Nasdaq
Crowdfund Insider
·
18 րոպե առաջ
XRP Treasury Firm Evernorth Clears Shareholder Vote Ahead Of Oct 8 Nasdaq Debut
The Business Journals
·
33 րոպե առաջ
NYSE suspends trading in Oregon public company once valued at $2B
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc